BDA
CVS icon

Borer Denton & Associates’s CVS Health CVS Stock Holding History

Borer Denton & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Sell
32,841
-690
-2% -$61.6K 1.11% 24
2026
Q1 		$2.41M Sell
33,531
-288
-0.9% -$22.2K 0.86% 29
2025
Q4 		$2.68M Buy
33,819
+8,187
+32% +$645K 0.9% 31
2025
Q3 		$1.93M Buy
25,632
+1,200
+5% +$82.2K 0.64% 32
2025
Q2 		$1.69M Sell
24,432
-2,885
-11% -$189K 0.58% 33
2025
Q1 		$1.85M Sell
27,317
-6,886
-20% -$412K 0.65% 32
2024
Q4 		$1.54M Sell
34,203
-14,807
-30% -$831K 0.53% 35
2024
Q3 		$3.08M Sell
49,010
-21,701
-31% -$1.27M 1.05% 27
2024
Q2 		$4.18M Sell
70,711
-6,930
-9% -$433K 1.52% 23
2024
Q1 		$6.19M Sell
77,641
-275
-0.4% -$21K 2.19% 19
2023
Q4 		$6.15M Sell
77,916
-2,175
-3% -$155K 2.36% 18
2023
Q3 		$5.59M Sell
80,091
-1,344
-2% -$95.2K 2.31% 19
2023
Q2 		$5.63M Buy
81,435
+1,025
+1% +$72.9K 2.22% 19
2023
Q1 		$5.98M Buy
80,410
+4,387
+6% +$368K 2.48% 17
2022
Q4 		$7.08M Buy
76,023
+1,275
+2% +$123K 3.14% 16
2022
Q3 		$7.13M Buy
74,748
+2,590
+4% +$256K 3.55% 13
2022
Q2 		$6.69M Sell
72,158
-50
-0.1% -$4.88K 3.22% 13
2022
Q1 		$7.31M Buy
+72,208
New +$7.59M 3.07% 15

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Borer Denton & Associates's CVS Position: Q2 2026 in Review

Borer Denton & Associates reduced its CVS Health (CVS) stake by 2.1% in Q2 2026, selling an estimated $61.6K and leaving 32,841 shares worth $3.4M. The position accounts for 1.11% of the portfolio, ranked #24.

Borer Denton & Associates first reported a position in CVS in Q1 2022 and has held it in 18 quarters since. The position peaked at $7.31M in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Borer Denton & Associates held 32,841 shares of CVS Health worth $3.4M as of Q2 2026.
  • Borer Denton & Associates sold 690 CVS Health shares in Q2 2026, an estimated $61.6K.
  • CVS Health made up 1.11% of Borer Denton & Associates's portfolio in Q2 2026, its #24 holding.
  • Borer Denton & Associates first reported a position in CVS Health in Q1 2022 and has held it in 18 quarters since.
  • Borer Denton & Associates's CVS Health position peaked at $7.31M in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Borer Denton & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.